Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Westphal

Showing results (291-300 of 309) with videos related to

Pageof 31
Sort By:
Molecular Cancer|August 10, 2023
Local delivery of hrBMP4 as an anticancer therapy in patients with recurrent glioblastoma: a first-in-human phase 1 dose escalation trialEelke M Bos, Elena Binda, Iris S C Verploegh, et al.
Acta Neuropathologica|March 19, 2015
Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groupsMichael Weller, Ruthild G Weber, Edith Willscher, et al.
Science Advances|March 14, 2018
Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesiclesFranz L Ricklefs, Quazim Alayo, Harald Krenzlin, et al.
Oncotarget|November 24, 2016
Prognostic relevance of miRNA-155 methylation in anaplastic gliomaMaximilian Georg Schliesser, Rainer Claus, Thomas Hielscher, et al.
European Journal of Cancer (Oxford, England : 1990)|May 22, 2012
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modalityRoger Stupp, Eric T Wong, Andrew A Kanner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of originAlbert Lai, Samir Kharbanda, Whitney B Pope, et al.
European Journal of Endocrinology|September 5, 2023
Defining benchmark outcomes for transsphenoidal surgery of pituitary adenomas: a multicenter analysisRichard Drexler, Roman Rotermund, Timothy R Smith, et al.
Nature Communications|February 5, 2025
Mapping naturally presented T cell antigens in medulloblastoma based on integrative multi-omicsJulia Velz, Lena K Freudenmann, Gioele Medici, et al.
Biorxiv : the Preprint Server for Biology|August 23, 2023
Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerabilityRichard Drexler, Robin Khatri, Thomas Sauvigny, et al.
Frontiers in Neurology|December 30, 2021
Enhancing Safety in Epilepsy Surgery (EASINESS): Study Protocol for a Retrospective, Multicenter, Open RegistryRichard Drexler, Sharona Ben-Haim, Christian G Bien, et al.
Pageof 31

Showing results (291-300 of 309) with videos related to

Sort By:
Pageof 31
Molecular Cancer|August 10, 2023
Local delivery of hrBMP4 as an anticancer therapy in patients with recurrent glioblastoma: a first-in-human phase 1 dose escalation trialEelke M Bos, Elena Binda, Iris S C Verploegh, et al.
Acta Neuropathologica|March 19, 2015
Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groupsMichael Weller, Ruthild G Weber, Edith Willscher, et al.
Science Advances|March 14, 2018
Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesiclesFranz L Ricklefs, Quazim Alayo, Harald Krenzlin, et al.
Oncotarget|November 24, 2016
Prognostic relevance of miRNA-155 methylation in anaplastic gliomaMaximilian Georg Schliesser, Rainer Claus, Thomas Hielscher, et al.
European Journal of Cancer (Oxford, England : 1990)|May 22, 2012
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modalityRoger Stupp, Eric T Wong, Andrew A Kanner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of originAlbert Lai, Samir Kharbanda, Whitney B Pope, et al.
European Journal of Endocrinology|September 5, 2023
Defining benchmark outcomes for transsphenoidal surgery of pituitary adenomas: a multicenter analysisRichard Drexler, Roman Rotermund, Timothy R Smith, et al.
Nature Communications|February 5, 2025
Mapping naturally presented T cell antigens in medulloblastoma based on integrative multi-omicsJulia Velz, Lena K Freudenmann, Gioele Medici, et al.
Biorxiv : the Preprint Server for Biology|August 23, 2023
Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerabilityRichard Drexler, Robin Khatri, Thomas Sauvigny, et al.
Frontiers in Neurology|December 30, 2021
Enhancing Safety in Epilepsy Surgery (EASINESS): Study Protocol for a Retrospective, Multicenter, Open RegistryRichard Drexler, Sharona Ben-Haim, Christian G Bien, et al.
Pageof 31